Qualigen Therapeutics Stock Analysis

Qualigen Stock Analysis Notes

The company has price-to-book ratio of 0.41. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Qualigen Therapeutics recorded earning per share (EPS) of 3635.0. The entity last dividend was issued on the 26th of May 2020. The firm had 1:50 split on the 5th of November 2024. Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California. Qualigen Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs people. To find out more about Qualigen Therapeutics contact Kevin II at 760 452 8111 or learn more at https://www.qlgntx.com.

Qualigen Therapeutics Investment Alerts

Qualigen Therapeutics Upcoming and Recent Events

Qualigen Largest EPS Surprises

View All Earnings Estimates

Qualigen Therapeutics Environmental, Social, and Governance (ESG) Scores

Qualigen Stock Institutional Investors

Note, although Qualigen Therapeutics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Qualigen Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.29 M.

Qualigen Profitablity

Management Efficiency

Qualigen Therapeutics has return on total asset (ROA) of (0.7507) % which means that it has lost $0.7507 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (8.4166) %, meaning that it created substantial loss on money invested by shareholders. Qualigen Therapeutics' management efficiency ratios could be used to measure how well Qualigen Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Qualigen Therapeutics' Return On Capital Employed is very stable compared to the past year. As of the 28th of November 2024, Return On Equity is likely to grow to 6.70, though Return On Tangible Assets are likely to grow to (6.27). At this time, Qualigen Therapeutics' Non Currrent Assets Other are very stable compared to the past year. As of the 28th of November 2024, Other Current Assets is likely to grow to about 1.4 M, while Total Assets are likely to drop about 1.9 M.

Technical Drivers

As of the 28th of November, Qualigen Therapeutics holds the Risk Adjusted Performance of (0.10), coefficient of variation of (694.77), and Variance of 45.49. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Qualigen Therapeutics, as well as the relationship between them.

Qualigen Therapeutics Price Movement Analysis

Qualigen Therapeutics Insider Trading Activities

Qualigen Therapeutics Outstanding Bonds

Qualigen Therapeutics Predictive Daily Indicators

Qualigen Therapeutics Corporate Filings

Qualigen Therapeutics Forecast Models

Qualigen Therapeutics' time-series forecasting models are one of many Qualigen Therapeutics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Qualigen Therapeutics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Qualigen Therapeutics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Qualigen shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Qualigen Therapeutics. By using and applying Qualigen Stock analysis, traders can create a robust methodology for identifying Qualigen entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Qualigen analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Qualigen analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Qualigen Therapeutics stock analysis indicators help investors evaluate how Qualigen Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Qualigen Therapeutics shares will generate the highest return on investment. By understating and applying Qualigen Therapeutics stock analysis, traders can identify Qualigen Therapeutics position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Qualigen Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Qualigen Stock, please use our How to Invest in Qualigen Therapeutics guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Qualigen Therapeutics. If investors know Qualigen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Qualigen Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Qualigen Therapeutics is measured differently than its book value, which is the value of Qualigen that is recorded on the company's balance sheet. Investors also form their own opinion of Qualigen Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Qualigen Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Qualigen Therapeutics' market value can be influenced by many factors that don't directly affect Qualigen Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Qualigen Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Qualigen Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Qualigen Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.